CK
CELG

Carnick & Kubik’s Celgene Corp CELG Stock Holding History

Carnick & Kubik’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$2K Buy
+20
New +$2.06K ﹤0.01% 965
2015
Q4 		– Sell
-20
Closed -$2.16K – 406
2015
Q3 		$2.16K Buy
+20
New +$2.48K ﹤0.01% 377

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Carnick & Kubik's CELG Position: Q1 2016 in Review

Carnick & Kubik opened a new position in Celgene Corp (CELG) in Q1 2016: 20 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #965 among its holdings. This is a return to the name: Carnick & Kubik previously reported a position in CELG as recently as Q3 2015.

Carnick & Kubik first reported a position in CELG in Q3 2015 and has held it in 2 quarters since. The position peaked at $2.16K in Q3 2015. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

  • Carnick & Kubik held 20 shares of Celgene Corp worth $2K as of Q1 2016.
  • Celgene Corp was a new Carnick & Kubik position in Q1 2016.
  • Celgene Corp made up ﹤0.01% of Carnick & Kubik's portfolio in Q1 2016, its #965 holding.
  • Carnick & Kubik first reported a position in Celgene Corp in Q3 2015 and has held it in 2 quarters since.
  • Carnick & Kubik's Celgene Corp position peaked at $2.16K in Q3 2015.
  • 1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.